Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
about
Standards of medical care in diabetes--2012Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve OutcomesStandards of medical care in diabetes--2013Therapeutic management of diabetic kidney disease.Clinical therapeutic strategies for early stage of diabetic kidney disease.Standards of medical care in diabetes--2010.Microalbuminuria and heart rate variability in adolescents with diabetes.Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.Standards of medical care in diabetes--2011.Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetesAssociation of microalbuminuria with ischemic heart disease in non-diabetic Asian-Indians: A case control study.Renal gene and protein expression signatures for prediction of kidney disease progressionRole of aliskiren in blood pressure control and renoprotectionPoor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and Nutrition Examination Survey.Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy).Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.Blood pressure control and nephroprotection in diabetes.Meta-analysis of genome-wide linkage scans for renal function traits.Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children.Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.Implications of albuminuria on kidney disease progression.Diabetic nephropathy: the proteinuria hypothesis.Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function.Albuminuria, renal dysfunction and circadian blood pressure rhythm in older men: a population-based longitudinal cohort studyIleal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitusHypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician.Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.Cardiometabolic syndrome and chronic kidney disease: what is the link?Early detection of renal disease/microalbuminuria in patients with the cardiometabolic syndrome.Higher levels of albuminuria within the normal range predict incident hypertension.Urinary total protein as the predictor of albuminuria in diabetic patientsThe relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot studyPreeclampsia and prevalence of microalbuminuria 10 years laterCorrelation between prediabetes conditions and microalbuminuria.Standards of medical care in diabetes--2009.Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
P2860
Q24632533-3220BD09-3FB9-4015-B5E9-907CD58920C7Q26744419-194DA0F9-16A0-4205-B12E-C89482A2826FQ29620309-D1BFFB2D-0B1E-48AB-A557-7317EA3E934BQ30362729-AB4C7BF3-19C3-4132-9F40-CB1340D5BB2AQ30363683-24F66F0D-6A7B-4029-8A1C-4E3A86D0760EQ33554238-66005E98-60CD-4FDA-9990-B8612B0F373BQ33642807-EFDA1C66-A73B-429A-9FA4-9981004CDD0EQ33697462-6A3DCB85-0465-4E2A-B167-6C2A4ADDA0C0Q34425055-63643D42-5EBD-4495-B613-7E6BEFAC6E01Q34595173-85670870-A755-47C6-9BBB-57E14E5EC99BQ34721211-1A84A5D0-4177-47AE-99F4-60887E08FD35Q34975515-7E2A4DE9-E40A-4B9A-B7C8-E67DF02C8E1EQ34982782-CE7490A0-5F27-45C1-A412-6E7ED90FB159Q35026735-28D66C73-C9FC-4635-A37D-8B73B954792CQ35144298-874FB60D-6C18-4480-83DA-3C2C5D9EC691Q35161366-CFC24467-0B70-4DAD-9795-58385094F669Q35212969-A9CC2B05-0ED7-4C60-BCA2-697924099A13Q35271574-C4D85A10-E2F6-4476-B72A-AC2B9E879404Q35686501-F4905BEC-D8CC-4403-AB23-26014E6BAD31Q35722933-C1224E43-144A-4BA9-B844-2AB0457B84F2Q35745738-CD741C95-DA72-4C72-AD8C-1EA0F367D06DQ35797168-E540ED76-3A4D-4F45-8B52-33CFAD2B12EAQ35810520-88837419-B86A-4136-8C8E-C245999BFA57Q35945756-86D6D871-C8AA-4492-A2A0-7FB7EF914439Q36061335-9E6D99C0-F634-4147-A0A7-D9B91A0A2410Q36087862-8E5759E5-3874-4768-82D1-D88CD8BE76B8Q36088870-7BA67630-3487-4D9B-AC14-593C50B8281DQ36107805-35482771-1B2D-4DDC-ADF9-02A91DFE7DEBQ36369676-A3ABF0A4-CE2E-4DDA-9A5A-565E19A38F2FQ36492059-74E6BA8F-7EAD-4231-A560-434971ACA5E6Q36901518-FC09B14B-4FDA-4F53-8963-95BAB6F31F78Q36904439-32713790-1E77-448F-B0E1-5AADC2992E58Q36906041-C69EC301-0A12-4938-9F92-523AD313F23BQ36957392-632B01B9-F89E-4165-8D4F-106BC1B1D65CQ36958293-F01ACF9E-CD0B-41F0-AAC4-86E0567C0D2DQ36980367-90C683EE-3EB2-4200-AF16-BB978191AE4BQ36987674-6DDD454A-718D-40EA-9856-5D55481BEAFCQ37036416-D3F583A3-1578-403E-81BC-A8365BFD5C5CQ37049808-23E6B972-0E84-4DD5-A930-218A52D94DD5Q37202153-0DE8ED46-DD22-446A-A414-90A491D1DF24
P2860
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@ast
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@en
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@nl
type
label
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@ast
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@en
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@nl
prefLabel
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@ast
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@en
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@nl
P2860
P1433
P1476
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
@en
P2093
George L Bakris
Jay P Garg
P2860
P356
10.1191/1358863X02VM412RA
P577
2002-02-01T00:00:00Z